 Howard An
Concepts (740)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 103 | 2021 | 243 | 14.210 |
Why?
| | Spinal Fusion | 86 | 2021 | 464 | 13.090 |
Why?
| | Cervical Vertebrae | 76 | 2021 | 343 | 11.370 |
Why?
| | Lumbar Vertebrae | 109 | 2022 | 469 | 10.520 |
Why?
| | Intervertebral Disc Displacement | 46 | 2022 | 121 | 7.190 |
Why?
| | Intervertebral Disc Degeneration | 36 | 2022 | 117 | 6.920 |
Why?
| | Diskectomy | 32 | 2021 | 181 | 6.110 |
Why?
| | Spinal Diseases | 36 | 2019 | 153 | 5.220 |
Why?
| | Radiculopathy | 18 | 2019 | 59 | 4.100 |
Why?
| | Spinal Stenosis | 21 | 2019 | 53 | 3.720 |
Why?
| | Laminectomy | 21 | 2020 | 66 | 3.490 |
Why?
| | Lordosis | 6 | 2021 | 32 | 3.360 |
Why?
| | Bone Screws | 21 | 2016 | 178 | 3.240 |
Why?
| | Humans | 276 | 2022 | 31481 | 3.130 |
Why?
| | Bone Morphogenetic Proteins | 26 | 2014 | 100 | 3.110 |
Why?
| | Postoperative Complications | 25 | 2021 | 1083 | 2.920 |
Why?
| | Spondylolisthesis | 9 | 2019 | 46 | 2.890 |
Why?
| | Low Back Pain | 25 | 2022 | 133 | 2.790 |
Why?
| | Thoracic Vertebrae | 23 | 2017 | 117 | 2.760 |
Why?
| | Spine | 18 | 2021 | 125 | 2.560 |
Why?
| | Middle Aged | 131 | 2021 | 11209 | 2.430 |
Why?
| | Animals | 91 | 2021 | 5312 | 2.410 |
Why?
| | Biomechanical Phenomena | 51 | 2017 | 719 | 2.380 |
Why?
| | Range of Motion, Articular | 30 | 2017 | 703 | 2.320 |
Why?
| | Adult | 116 | 2021 | 9779 | 2.260 |
Why?
| | Transforming Growth Factor beta | 14 | 2014 | 126 | 2.260 |
Why?
| | Male | 143 | 2022 | 17583 | 2.200 |
Why?
| | Female | 144 | 2022 | 18253 | 2.170 |
Why?
| | Lumbosacral Region | 14 | 2021 | 71 | 2.170 |
Why?
| | Tomography, X-Ray Computed | 28 | 2021 | 891 | 2.150 |
Why?
| | Imaging, Three-Dimensional | 10 | 2021 | 233 | 2.090 |
Why?
| | Internal Fixators | 13 | 2012 | 53 | 2.080 |
Why?
| | Finite Element Analysis | 18 | 2014 | 71 | 2.050 |
Why?
| | Chondrocytes | 14 | 2019 | 216 | 2.000 |
Why?
| | Decompression, Surgical | 14 | 2019 | 146 | 1.990 |
Why?
| | Radiography | 45 | 2019 | 717 | 1.870 |
Why?
| | Retrospective Studies | 40 | 2022 | 3591 | 1.840 |
Why?
| | Back Pain | 10 | 2022 | 49 | 1.820 |
Why?
| | Spinal Fractures | 17 | 2021 | 63 | 1.810 |
Why?
| | Orthopedic Procedures | 12 | 2013 | 322 | 1.760 |
Why?
| | Bone Plates | 9 | 2009 | 57 | 1.750 |
Why?
| | Aged | 98 | 2021 | 10295 | 1.660 |
Why?
| | Bone Transplantation | 19 | 2018 | 231 | 1.610 |
Why?
| | Proteoglycans | 29 | 2018 | 419 | 1.600 |
Why?
| | Rabbits | 22 | 2020 | 326 | 1.580 |
Why?
| | Kyphosis | 6 | 2012 | 26 | 1.570 |
Why?
| | Disease Models, Animal | 20 | 2015 | 832 | 1.560 |
Why?
| | Microsatellite Repeats | 3 | 2014 | 18 | 1.550 |
Why?
| | Occipital Bone | 3 | 2016 | 13 | 1.500 |
Why?
| | Genetic Variation | 3 | 2014 | 113 | 1.470 |
Why?
| | Magnetic Resonance Imaging | 40 | 2022 | 1273 | 1.460 |
Why?
| | Treatment Outcome | 43 | 2021 | 3910 | 1.440 |
Why?
| | Zygapophyseal Joint | 14 | 2021 | 47 | 1.380 |
Why?
| | Pedicle Screws | 3 | 2017 | 13 | 1.340 |
Why?
| | Bone Morphogenetic Protein 7 | 16 | 2015 | 65 | 1.300 |
Why?
| | Contrast Media | 6 | 2017 | 144 | 1.290 |
Why?
| | Atlanto-Occipital Joint | 3 | 2019 | 18 | 1.290 |
Why?
| | Scoliosis | 3 | 2020 | 35 | 1.180 |
Why?
| | Cadaver | 23 | 2019 | 356 | 1.080 |
Why?
| | Osseointegration | 5 | 2014 | 72 | 1.060 |
Why?
| | Spinal Cord Diseases | 4 | 2019 | 51 | 1.060 |
Why?
| | Extracellular Matrix | 14 | 2014 | 92 | 1.050 |
Why?
| | Stem Cell Transplantation | 4 | 2018 | 54 | 1.020 |
Why?
| | Cells, Cultured | 32 | 2019 | 802 | 1.020 |
Why?
| | Models, Biological | 11 | 2012 | 428 | 1.000 |
Why?
| | Fishes | 2 | 2014 | 5 | 1.000 |
Why?
| | Cattle | 30 | 2018 | 260 | 0.990 |
Why?
| | Notochord | 4 | 2008 | 6 | 0.980 |
Why?
| | Reoperation | 9 | 2020 | 938 | 0.980 |
Why?
| | Biological Products | 3 | 2011 | 38 | 0.970 |
Why?
| | Neck Pain | 4 | 2019 | 27 | 0.960 |
Why?
| | Joint Instability | 14 | 2013 | 374 | 0.950 |
Why?
| | Spinal Nerve Roots | 13 | 2004 | 29 | 0.940 |
Why?
| | Telemedicine | 5 | 2022 | 99 | 0.920 |
Why?
| | Growth Substances | 5 | 2006 | 38 | 0.890 |
Why?
| | Weight-Bearing | 15 | 2014 | 193 | 0.880 |
Why?
| | Artificial Intelligence | 1 | 2021 | 12 | 0.870 |
Why?
| | Glycopyrrolate | 1 | 2021 | 5 | 0.850 |
Why?
| | Urinary Retention | 1 | 2021 | 12 | 0.840 |
Why?
| | Spinal Neoplasms | 6 | 2019 | 36 | 0.820 |
Why?
| | Cell Movement | 5 | 2020 | 119 | 0.810 |
Why?
| | Microsurgery | 2 | 2019 | 46 | 0.810 |
Why?
| | Orthopedics | 5 | 2013 | 133 | 0.800 |
Why?
| | Atlanto-Axial Joint | 5 | 2013 | 19 | 0.800 |
Why?
| | Neurosurgical Procedures | 7 | 2009 | 169 | 0.800 |
Why?
| | Calcium Phosphates | 5 | 2014 | 30 | 0.790 |
Why?
| | Arthroplasty, Replacement | 3 | 2006 | 147 | 0.780 |
Why?
| | Apoptosis | 3 | 2013 | 292 | 0.780 |
Why?
| | Fracture Fixation, Internal | 6 | 2011 | 71 | 0.770 |
Why?
| | Hypoglossal Nerve | 1 | 2019 | 3 | 0.770 |
Why?
| | Carotid Artery, Internal | 1 | 2019 | 31 | 0.760 |
Why?
| | Obesity | 3 | 2019 | 338 | 0.750 |
Why?
| | Patient Discharge | 2 | 2020 | 163 | 0.740 |
Why?
| | Prostheses and Implants | 6 | 2010 | 166 | 0.730 |
Why?
| | Cicatrix | 6 | 2006 | 13 | 0.730 |
Why?
| | Interleukin-8 | 2 | 2016 | 38 | 0.730 |
Why?
| | Genetics, Population | 3 | 2014 | 4 | 0.730 |
Why?
| | Bone Cements | 5 | 2007 | 91 | 0.720 |
Why?
| | Rotation | 12 | 2016 | 158 | 0.720 |
Why?
| | Risk Factors | 16 | 2022 | 2664 | 0.720 |
Why?
| | Collagen Type II | 5 | 2018 | 36 | 0.720 |
Why?
| | Postural Balance | 1 | 2020 | 127 | 0.710 |
Why?
| | Fibroblasts | 2 | 2018 | 98 | 0.700 |
Why?
| | Arthritis, Rheumatoid | 4 | 2013 | 379 | 0.700 |
Why?
| | Bone Density | 11 | 2019 | 141 | 0.690 |
Why?
| | Organometallic Compounds | 2 | 2017 | 23 | 0.690 |
Why?
| | Aorta | 2 | 2017 | 31 | 0.680 |
Why?
| | Ganglia, Spinal | 6 | 2016 | 47 | 0.670 |
Why?
| | Stress, Mechanical | 12 | 2013 | 198 | 0.670 |
Why?
| | Disease Progression | 8 | 2017 | 861 | 0.650 |
Why?
| | Salvage Therapy | 1 | 2017 | 42 | 0.650 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 51 | 0.650 |
Why?
| | Young Adult | 19 | 2021 | 2277 | 0.650 |
Why?
| | Bone Substitutes | 3 | 2014 | 34 | 0.650 |
Why?
| | Cerebral Arteries | 1 | 2017 | 37 | 0.640 |
Why?
| | Gene Expression Regulation | 4 | 2015 | 351 | 0.640 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2012 | 59 | 0.620 |
Why?
| | Cell Transplantation | 4 | 2015 | 28 | 0.620 |
Why?
| | Anesthetics, Local | 2 | 2016 | 86 | 0.620 |
Why?
| | Interleukins | 1 | 2016 | 42 | 0.610 |
Why?
| | Cell Culture Techniques | 6 | 2013 | 52 | 0.600 |
Why?
| | Tissue Engineering | 5 | 2018 | 50 | 0.590 |
Why?
| | Nerve Compression Syndromes | 7 | 2004 | 28 | 0.590 |
Why?
| | Cartilage, Articular | 10 | 2015 | 586 | 0.580 |
Why?
| | Epidural Space | 3 | 2016 | 22 | 0.580 |
Why?
| | Osteotomy | 2 | 2020 | 161 | 0.580 |
Why?
| | Total Disc Replacement | 2 | 2012 | 15 | 0.580 |
Why?
| | Biocompatible Materials | 2 | 2014 | 112 | 0.570 |
Why?
| | Cartilage | 3 | 2008 | 168 | 0.570 |
Why?
| | Disability Evaluation | 9 | 2019 | 332 | 0.570 |
Why?
| | Bone Regeneration | 4 | 2011 | 63 | 0.570 |
Why?
| | Adolescent | 22 | 2022 | 2667 | 0.570 |
Why?
| | Surgeons | 3 | 2021 | 84 | 0.570 |
Why?
| | Computer Simulation | 8 | 2016 | 249 | 0.570 |
Why?
| | Movement | 8 | 2011 | 167 | 0.560 |
Why?
| | Pain Measurement | 8 | 2019 | 476 | 0.560 |
Why?
| | Pain, Postoperative | 4 | 2020 | 306 | 0.560 |
Why?
| | Compressive Strength | 6 | 2012 | 37 | 0.560 |
Why?
| | Bass | 1 | 2014 | 1 | 0.550 |
Why?
| | Models, Anatomic | 10 | 2018 | 68 | 0.550 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2014 | 5 | 0.550 |
Why?
| | Sensitivity and Specificity | 11 | 2015 | 580 | 0.550 |
Why?
| | Ossification of Posterior Longitudinal Ligament | 1 | 2014 | 3 | 0.540 |
Why?
| | Polymethyl Methacrylate | 5 | 2007 | 16 | 0.540 |
Why?
| | Anatomy, Comparative | 1 | 2014 | 1 | 0.530 |
Why?
| | Follow-Up Studies | 16 | 2020 | 2028 | 0.530 |
Why?
| | Mammals | 1 | 2014 | 16 | 0.530 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2014 | 45 | 0.520 |
Why?
| | Epidural Abscess | 2 | 2006 | 7 | 0.520 |
Why?
| | Collagen | 10 | 2018 | 111 | 0.520 |
Why?
| | In Vitro Techniques | 10 | 2014 | 248 | 0.520 |
Why?
| | Rats | 11 | 2018 | 966 | 0.520 |
Why?
| | Genetic Therapy | 5 | 2012 | 93 | 0.520 |
Why?
| | Electrocoagulation | 2 | 2003 | 14 | 0.510 |
Why?
| | Growth Plate | 3 | 2014 | 29 | 0.500 |
Why?
| | Spinal Osteophytosis | 5 | 2007 | 14 | 0.490 |
Why?
| | Dogs | 10 | 2007 | 283 | 0.480 |
Why?
| | RNA, Messenger | 8 | 2015 | 371 | 0.480 |
Why?
| | Anthropometry | 3 | 2011 | 56 | 0.470 |
Why?
| | Durapatite | 3 | 2014 | 11 | 0.460 |
Why?
| | Fractures, Ununited | 3 | 2009 | 20 | 0.460 |
Why?
| | Aged, 80 and over | 35 | 2017 | 5234 | 0.450 |
Why?
| | Elasticity | 6 | 2013 | 53 | 0.450 |
Why?
| | Image Processing, Computer-Assisted | 8 | 2021 | 227 | 0.450 |
Why?
| | Fibronectins | 4 | 2015 | 31 | 0.450 |
Why?
| | Interleukin-1 | 6 | 2014 | 91 | 0.440 |
Why?
| | Osteoarthritis | 8 | 2010 | 369 | 0.440 |
Why?
| | Reproducibility of Results | 6 | 2016 | 886 | 0.430 |
Why?
| | Regeneration | 3 | 2006 | 30 | 0.430 |
Why?
| | Proteins | 2 | 2011 | 94 | 0.430 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2013 | 32 | 0.430 |
Why?
| | Polyethylene | 1 | 2012 | 127 | 0.430 |
Why?
| | Republic of Korea | 4 | 2015 | 9 | 0.430 |
Why?
| | Osteomyelitis | 2 | 2006 | 23 | 0.430 |
Why?
| | High Mobility Group Proteins | 2 | 2007 | 3 | 0.420 |
Why?
| | Metals | 1 | 2012 | 157 | 0.420 |
Why?
| | Ossification, Heterotopic | 5 | 2014 | 40 | 0.410 |
Why?
| | Osteogenesis | 3 | 2005 | 94 | 0.410 |
Why?
| | Sacrum | 4 | 2011 | 30 | 0.410 |
Why?
| | Diagnostic Imaging | 5 | 2006 | 98 | 0.400 |
Why?
| | Homeostasis | 7 | 2014 | 110 | 0.400 |
Why?
| | Bacterial Infections | 2 | 2006 | 71 | 0.400 |
Why?
| | Signal Transduction | 10 | 2017 | 588 | 0.400 |
Why?
| | Osteoporosis | 5 | 2005 | 74 | 0.390 |
Why?
| | Tuberculosis, Spinal | 1 | 2009 | 3 | 0.390 |
Why?
| | Patient Satisfaction | 5 | 2022 | 315 | 0.390 |
Why?
| | Headache | 2 | 2007 | 52 | 0.380 |
Why?
| | Time Factors | 13 | 2019 | 1902 | 0.380 |
Why?
| | Ethics, Medical | 1 | 2009 | 17 | 0.380 |
Why?
| | Transcription Factors | 2 | 2007 | 180 | 0.380 |
Why?
| | Dose-Response Relationship, Drug | 9 | 2016 | 512 | 0.380 |
Why?
| | Wounds, Penetrating | 2 | 2008 | 10 | 0.370 |
Why?
| | Lactoferrin | 3 | 2013 | 16 | 0.370 |
Why?
| | Pain | 6 | 2008 | 336 | 0.370 |
Why?
| | Vertebral Artery | 1 | 2008 | 8 | 0.360 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 28 | 0.360 |
Why?
| | Gelatin Sponge, Absorbable | 2 | 2006 | 6 | 0.360 |
Why?
| | Real-Time Polymerase Chain Reaction | 4 | 2016 | 60 | 0.360 |
Why?
| | Smoking | 6 | 2000 | 202 | 0.360 |
Why?
| | Sex Characteristics | 5 | 2019 | 128 | 0.360 |
Why?
| | Angiography | 1 | 2008 | 53 | 0.360 |
Why?
| | Hemostatics | 2 | 2006 | 11 | 0.360 |
Why?
| | First Aid | 1 | 2008 | 2 | 0.350 |
Why?
| | Cerebral Palsy | 1 | 2008 | 10 | 0.350 |
Why?
| | Extracellular Matrix Proteins | 4 | 2012 | 176 | 0.350 |
Why?
| | Staphylococcal Infections | 3 | 2006 | 176 | 0.350 |
Why?
| | Transduction, Genetic | 4 | 2009 | 22 | 0.340 |
Why?
| | Triage | 1 | 2008 | 30 | 0.340 |
Why?
| | Neurons, Afferent | 2 | 2007 | 7 | 0.340 |
Why?
| | Emergency Medicine | 1 | 2008 | 39 | 0.330 |
Why?
| | Spinal Cord Compression | 4 | 2013 | 30 | 0.330 |
Why?
| | Vertebroplasty | 1 | 2007 | 11 | 0.320 |
Why?
| | ADAM Proteins | 6 | 2014 | 95 | 0.320 |
Why?
| | Bone Matrix | 4 | 2014 | 33 | 0.320 |
Why?
| | Species Specificity | 3 | 2014 | 78 | 0.320 |
Why?
| | Bone Diseases, Infectious | 1 | 2006 | 2 | 0.300 |
Why?
| | Tissue Adhesions | 1 | 2006 | 10 | 0.300 |
Why?
| | Thrombin | 1 | 2006 | 14 | 0.300 |
Why?
| | Orthopedic Fixation Devices | 2 | 2005 | 24 | 0.300 |
Why?
| | Amides | 2 | 2016 | 21 | 0.300 |
Why?
| | Abscess | 1 | 2006 | 23 | 0.290 |
Why?
| | Fractures, Spontaneous | 3 | 2005 | 11 | 0.290 |
Why?
| | Neurofibromatosis 1 | 1 | 2005 | 4 | 0.290 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2005 | 7 | 0.290 |
Why?
| | Autocrine Communication | 1 | 2005 | 3 | 0.290 |
Why?
| | Ki-67 Antigen | 1 | 2005 | 17 | 0.290 |
Why?
| | Recovery of Function | 5 | 2012 | 309 | 0.290 |
Why?
| | Paracrine Communication | 1 | 2005 | 8 | 0.290 |
Why?
| | Spondylosis | 3 | 2017 | 33 | 0.290 |
Why?
| | Inflammation | 2 | 2020 | 360 | 0.280 |
Why?
| | Coated Materials, Biocompatible | 1 | 2005 | 41 | 0.280 |
Why?
| | Age Factors | 8 | 2019 | 943 | 0.280 |
Why?
| | Debridement | 2 | 2006 | 99 | 0.280 |
Why?
| | Aquaculture | 2 | 2014 | 2 | 0.280 |
Why?
| | Aggrecans | 5 | 2013 | 200 | 0.280 |
Why?
| | Spinal Cord | 3 | 2006 | 99 | 0.270 |
Why?
| | Gene Frequency | 2 | 2014 | 80 | 0.270 |
Why?
| | Polymorphism, Genetic | 2 | 2014 | 87 | 0.260 |
Why?
| | Pandemics | 3 | 2021 | 203 | 0.260 |
Why?
| | Alleles | 2 | 2014 | 221 | 0.260 |
Why?
| | Implants, Experimental | 1 | 2004 | 29 | 0.260 |
Why?
| | Joint Prosthesis | 1 | 2005 | 77 | 0.260 |
Why?
| | Transplantation, Autologous | 7 | 2012 | 223 | 0.260 |
Why?
| | Gene Expression | 6 | 2016 | 272 | 0.260 |
Why?
| | Fibroblast Growth Factor 2 | 4 | 2013 | 24 | 0.260 |
Why?
| | Prospective Studies | 13 | 2020 | 1934 | 0.260 |
Why?
| | Cohort Studies | 9 | 2019 | 2014 | 0.250 |
Why?
| | Allografts | 2 | 2015 | 171 | 0.250 |
Why?
| | Cell Survival | 7 | 2013 | 181 | 0.250 |
Why?
| | Inbreeding | 2 | 2014 | 3 | 0.250 |
Why?
| | Bone Wires | 4 | 2012 | 12 | 0.240 |
Why?
| | Genotype | 2 | 2014 | 423 | 0.240 |
Why?
| | Biglycan | 3 | 2016 | 17 | 0.240 |
Why?
| | Torsion Abnormality | 4 | 2007 | 13 | 0.240 |
Why?
| | Severity of Illness Index | 9 | 2015 | 1240 | 0.230 |
Why?
| | Observer Variation | 3 | 2016 | 146 | 0.230 |
Why?
| | Rats, Sprague-Dawley | 5 | 2016 | 494 | 0.230 |
Why?
| | Awards and Prizes | 1 | 2022 | 24 | 0.230 |
Why?
| | Anti-Bacterial Agents | 2 | 2006 | 412 | 0.220 |
Why?
| | Risk Assessment | 4 | 2021 | 806 | 0.220 |
Why?
| | Lipopolysaccharides | 3 | 2013 | 138 | 0.220 |
Why?
| | Pseudarthrosis | 4 | 2009 | 13 | 0.220 |
Why?
| | Recurrence | 4 | 2019 | 389 | 0.220 |
Why?
| | Mice | 6 | 2014 | 1894 | 0.220 |
Why?
| | Carrier Proteins | 4 | 2013 | 129 | 0.220 |
Why?
| | Spondylitis | 1 | 2001 | 3 | 0.220 |
Why?
| | Spinal Canal | 5 | 2004 | 15 | 0.210 |
Why?
| | Prosthesis Design | 3 | 2017 | 511 | 0.210 |
Why?
| | Prostatic Hyperplasia | 1 | 2021 | 14 | 0.210 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2006 | 300 | 0.210 |
Why?
| | Anesthesia | 1 | 2021 | 29 | 0.210 |
Why?
| | Receptors, CCR1 | 1 | 2020 | 2 | 0.210 |
Why?
| | Chemokines, CC | 1 | 2020 | 8 | 0.210 |
Why?
| | Hematoma | 2 | 2014 | 24 | 0.210 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 34 | 0.200 |
Why?
| | Intraoperative Complications | 2 | 2018 | 76 | 0.200 |
Why?
| | Feasibility Studies | 3 | 2016 | 281 | 0.200 |
Why?
| | Diagnosis, Differential | 7 | 2001 | 467 | 0.200 |
Why?
| | Endoscopy | 2 | 2006 | 181 | 0.200 |
Why?
| | Dura Mater | 2 | 2018 | 21 | 0.200 |
Why?
| | Drug Therapy, Combination | 1 | 2001 | 265 | 0.200 |
Why?
| | Ilium | 3 | 2012 | 29 | 0.200 |
Why?
| | Nerve Growth Factor | 3 | 2015 | 32 | 0.200 |
Why?
| | Immunohistochemistry | 6 | 2015 | 494 | 0.200 |
Why?
| | Forecasting | 4 | 2006 | 134 | 0.200 |
Why?
| | Cell Differentiation | 2 | 2018 | 174 | 0.190 |
Why?
| | Odds Ratio | 1 | 2021 | 327 | 0.190 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 55 | 0.190 |
Why?
| | Prosthesis Failure | 2 | 2017 | 534 | 0.190 |
Why?
| | Models, Animal | 3 | 2018 | 149 | 0.190 |
Why?
| | Blotting, Western | 6 | 2015 | 225 | 0.190 |
Why?
| | Interleukin-4 | 1 | 2019 | 36 | 0.190 |
Why?
| | Leg | 1 | 2019 | 51 | 0.190 |
Why?
| | DNA | 7 | 2009 | 139 | 0.190 |
Why?
| | Carcinoma, Renal Cell | 1 | 2019 | 46 | 0.190 |
Why?
| | Analgesia | 1 | 2019 | 39 | 0.180 |
Why?
| | Ligamentum Flavum | 2 | 2015 | 6 | 0.180 |
Why?
| | Time-to-Treatment | 1 | 2019 | 37 | 0.180 |
Why?
| | Recombinant Proteins | 4 | 2014 | 295 | 0.180 |
Why?
| | Kidney Neoplasms | 1 | 2019 | 78 | 0.180 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 26 | 0.180 |
Why?
| | Disabled Persons | 1 | 2020 | 119 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 191 | 0.180 |
Why?
| | Torque | 2 | 2017 | 29 | 0.180 |
Why?
| | Absorptiometry, Photon | 5 | 2005 | 83 | 0.180 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 181 | 0.180 |
Why?
| | Constriction, Pathologic | 2 | 2017 | 39 | 0.180 |
Why?
| | Perioperative Care | 1 | 1999 | 75 | 0.180 |
Why?
| | Orchiectomy | 1 | 2018 | 7 | 0.180 |
Why?
| | Watchful Waiting | 1 | 2018 | 10 | 0.180 |
Why?
| | Organ Culture Techniques | 5 | 2013 | 38 | 0.180 |
Why?
| | Random Allocation | 3 | 2015 | 164 | 0.180 |
Why?
| | Ambulatory Surgical Procedures | 1 | 1999 | 81 | 0.170 |
Why?
| | Osteoarthritis, Spine | 2 | 2015 | 7 | 0.170 |
Why?
| | Prognosis | 5 | 2019 | 1028 | 0.170 |
Why?
| | Software | 2 | 2016 | 74 | 0.170 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 109 | 0.170 |
Why?
| | Graft Survival | 2 | 2015 | 111 | 0.170 |
Why?
| | Testicular Neoplasms | 1 | 2018 | 26 | 0.170 |
Why?
| | Incidental Findings | 1 | 2018 | 20 | 0.170 |
Why?
| | Hydrocephalus | 1 | 2018 | 31 | 0.170 |
Why?
| | Coronavirus Infections | 1 | 2020 | 97 | 0.170 |
Why?
| | Predictive Value of Tests | 6 | 2022 | 637 | 0.170 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 102 | 0.170 |
Why?
| | Goats | 3 | 2014 | 10 | 0.170 |
Why?
| | Arthrography | 2 | 2010 | 26 | 0.170 |
Why?
| | Sodium Chloride | 1 | 1998 | 44 | 0.170 |
Why?
| | Peptide Fragments | 3 | 2014 | 122 | 0.170 |
Why?
| | Cerebral Veins | 1 | 2017 | 3 | 0.170 |
Why?
| | Materials Testing | 2 | 2017 | 140 | 0.170 |
Why?
| | Signal-To-Noise Ratio | 1 | 2017 | 7 | 0.170 |
Why?
| | Reconstructive Surgical Procedures | 3 | 2011 | 226 | 0.160 |
Why?
| | Adipose Tissue | 1 | 2018 | 98 | 0.160 |
Why?
| | Receptors, CCR5 | 1 | 2017 | 29 | 0.160 |
Why?
| | Rats, Wistar | 2 | 2008 | 64 | 0.160 |
Why?
| | SOX9 Transcription Factor | 4 | 2013 | 15 | 0.160 |
Why?
| | Lipomatosis | 1 | 2016 | 4 | 0.160 |
Why?
| | Sensory System Agents | 1 | 2016 | 5 | 0.160 |
Why?
| | Capsaicin | 1 | 2016 | 12 | 0.160 |
Why?
| | Substance P | 1 | 2016 | 19 | 0.160 |
Why?
| | Chondroitin ABC Lyase | 2 | 2007 | 6 | 0.160 |
Why?
| | Arthroplasty | 1 | 2017 | 125 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 1 | 2017 | 85 | 0.150 |
Why?
| | Interleukin-7 | 1 | 2016 | 25 | 0.150 |
Why?
| | Manipulation, Spinal | 1 | 2016 | 5 | 0.150 |
Why?
| | Torsion, Mechanical | 1 | 2016 | 4 | 0.150 |
Why?
| | Cell Proliferation | 7 | 2016 | 232 | 0.150 |
Why?
| | rho-Associated Kinases | 1 | 2016 | 6 | 0.150 |
Why?
| | Blood Platelets | 2 | 2006 | 52 | 0.150 |
Why?
| | Casts, Surgical | 2 | 1997 | 6 | 0.150 |
Why?
| | Interleukin-10 | 1 | 2016 | 42 | 0.150 |
Why?
| | Clinical Trials as Topic | 2 | 2012 | 378 | 0.150 |
Why?
| | Cerebral Hemorrhage | 1 | 2018 | 141 | 0.150 |
Why?
| | Adenoviridae | 4 | 2009 | 25 | 0.150 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 43 | 0.150 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 148 | 0.150 |
Why?
| | Gadolinium | 2 | 1998 | 12 | 0.150 |
Why?
| | Catheters, Indwelling | 1 | 2016 | 30 | 0.150 |
Why?
| | Pyridines | 1 | 2016 | 50 | 0.150 |
Why?
| | Microspheres | 2 | 2013 | 30 | 0.150 |
Why?
| | Equipment Design | 1 | 2016 | 198 | 0.150 |
Why?
| | Analgesia, Epidural | 1 | 2016 | 61 | 0.140 |
Why?
| | Immunoenzyme Techniques | 2 | 2005 | 54 | 0.140 |
Why?
| | Tissue Preservation | 1 | 1995 | 6 | 0.140 |
Why?
| | Neuralgia | 1 | 2015 | 14 | 0.140 |
Why?
| | Cell Division | 4 | 2008 | 122 | 0.140 |
Why?
| | Spinal Nerves | 2 | 2010 | 6 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 405 | 0.140 |
Why?
| | Marine Biology | 1 | 2014 | 1 | 0.140 |
Why?
| | Genetic Drift | 1 | 2014 | 1 | 0.140 |
Why?
| | Joint Capsule | 1 | 2015 | 45 | 0.140 |
Why?
| | Graft Rejection | 1 | 2015 | 84 | 0.140 |
Why?
| | Fisheries | 1 | 2014 | 1 | 0.140 |
Why?
| | Down-Regulation | 1 | 2015 | 134 | 0.140 |
Why?
| | Longitudinal Ligaments | 1 | 2014 | 2 | 0.140 |
Why?
| | Geography | 1 | 2014 | 22 | 0.140 |
Why?
| | Reference Values | 6 | 2009 | 260 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 81 | 0.130 |
Why?
| | Cytokines | 3 | 2017 | 364 | 0.130 |
Why?
| | Patient Selection | 4 | 2010 | 264 | 0.130 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2013 | 60 | 0.130 |
Why?
| | Neuroprotective Agents | 2 | 2005 | 66 | 0.130 |
Why?
| | Iohexol | 1 | 2013 | 5 | 0.130 |
Why?
| | Iopamidol | 1 | 2013 | 3 | 0.130 |
Why?
| | Bone and Bones | 2 | 2012 | 110 | 0.130 |
Why?
| | Child | 5 | 2022 | 1572 | 0.130 |
Why?
| | Aging | 6 | 2012 | 1614 | 0.130 |
Why?
| | MicroRNAs | 1 | 2014 | 63 | 0.130 |
Why?
| | Lidocaine | 1 | 2013 | 44 | 0.130 |
Why?
| | Analysis of Variance | 5 | 2015 | 364 | 0.130 |
Why?
| | Bupivacaine | 1 | 2013 | 55 | 0.120 |
Why?
| | Biological Factors | 1 | 2013 | 9 | 0.120 |
Why?
| | Diabetes Complications | 1 | 1993 | 74 | 0.120 |
Why?
| | Staphylococcus aureus | 2 | 2006 | 87 | 0.120 |
Why?
| | Transplantation, Homologous | 3 | 2003 | 292 | 0.120 |
Why?
| | Genetic Vectors | 3 | 2008 | 71 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2014 | 399 | 0.120 |
Why?
| | Spondylitis, Ankylosing | 1 | 2013 | 43 | 0.120 |
Why?
| | Neurons | 1 | 2016 | 407 | 0.120 |
Why?
| | Stroke | 1 | 2017 | 367 | 0.120 |
Why?
| | Menisci, Tibial | 1 | 2015 | 166 | 0.120 |
Why?
| | Fibroblast Growth Factors | 2 | 2013 | 9 | 0.120 |
Why?
| | Orthopedic Equipment | 2 | 2006 | 7 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2014 | 230 | 0.120 |
Why?
| | Glycerol | 1 | 2012 | 3 | 0.120 |
Why?
| | Physical Stimulation | 1 | 2012 | 17 | 0.120 |
Why?
| | Tibial Fractures | 2 | 1990 | 13 | 0.120 |
Why?
| | United States | 6 | 2017 | 2539 | 0.120 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 16 | 0.120 |
Why?
| | Enzyme Inhibitors | 2 | 2016 | 160 | 0.120 |
Why?
| | Protein Kinase C-delta | 1 | 2011 | 13 | 0.110 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 95 | 0.110 |
Why?
| | Fracture Healing | 1 | 2012 | 41 | 0.110 |
Why?
| | Blood Loss, Surgical | 3 | 2019 | 71 | 0.110 |
Why?
| | Procollagen N-Endopeptidase | 2 | 2008 | 30 | 0.110 |
Why?
| | Oxidative Stress | 2 | 2012 | 140 | 0.110 |
Why?
| | Up-Regulation | 5 | 2015 | 220 | 0.110 |
Why?
| | Neck | 3 | 2002 | 25 | 0.110 |
Why?
| | Metabolism | 2 | 2010 | 11 | 0.100 |
Why?
| | Preoperative Care | 1 | 2012 | 146 | 0.100 |
Why?
| | Combined Modality Therapy | 3 | 2005 | 456 | 0.100 |
Why?
| | Incidence | 3 | 2021 | 829 | 0.100 |
Why?
| | Psoas Muscles | 1 | 2010 | 6 | 0.100 |
Why?
| | Biopsy | 3 | 2015 | 283 | 0.100 |
Why?
| | Intervertebral Disc Chemolysis | 2 | 2007 | 5 | 0.100 |
Why?
| | Osteoarthritis, Knee | 1 | 2015 | 366 | 0.100 |
Why?
| | Patient Rights | 1 | 2009 | 4 | 0.100 |
Why?
| | Injections, Spinal | 2 | 2007 | 54 | 0.100 |
Why?
| | Femoral Neck Fractures | 1 | 1989 | 13 | 0.090 |
Why?
| | Conflict of Interest | 1 | 2009 | 19 | 0.090 |
Why?
| | Fractures, Closed | 1 | 1989 | 2 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 230 | 0.090 |
Why?
| | Equipment Failure Analysis | 1 | 2009 | 116 | 0.090 |
Why?
| | Ulna Fractures | 1 | 1989 | 6 | 0.090 |
Why?
| | Phytoestrogens | 1 | 2008 | 4 | 0.090 |
Why?
| | Dupuytren Contracture | 1 | 1988 | 1 | 0.090 |
Why?
| | Stilbenes | 1 | 2008 | 8 | 0.090 |
Why?
| | Hip Fractures | 1 | 1989 | 30 | 0.090 |
Why?
| | Fruit | 1 | 2008 | 20 | 0.090 |
Why?
| | Chronic Disease | 3 | 2007 | 544 | 0.090 |
Why?
| | Chemotaxis | 1 | 2008 | 6 | 0.090 |
Why?
| | Solubility | 1 | 2008 | 39 | 0.090 |
Why?
| | Culture Media, Conditioned | 1 | 2008 | 33 | 0.090 |
Why?
| | Pubic Bone | 1 | 1988 | 3 | 0.090 |
Why?
| | Reflex Sympathetic Dystrophy | 1 | 1988 | 5 | 0.090 |
Why?
| | Paralysis | 2 | 1992 | 17 | 0.090 |
Why?
| | Lifting | 1 | 2008 | 8 | 0.090 |
Why?
| | Phosphorylation | 3 | 2013 | 199 | 0.090 |
Why?
| | Injections | 2 | 2005 | 59 | 0.090 |
Why?
| | Pulmonary Embolism | 2 | 1997 | 57 | 0.090 |
Why?
| | Single-Blind Method | 2 | 2005 | 132 | 0.090 |
Why?
| | Bone Diseases | 1 | 2008 | 25 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 35 | 0.080 |
Why?
| | Caspases | 1 | 2007 | 32 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2007 | 32 | 0.080 |
Why?
| | Hydrogen Peroxide | 1 | 2007 | 46 | 0.080 |
Why?
| | Porosity | 4 | 2011 | 69 | 0.080 |
Why?
| | Decorin | 2 | 2009 | 19 | 0.080 |
Why?
| | Postoperative Period | 3 | 2019 | 295 | 0.080 |
Why?
| | Endopeptidases | 1 | 2007 | 58 | 0.080 |
Why?
| | Physical Therapy Modalities | 1 | 2008 | 70 | 0.080 |
Why?
| | Chondroitin Sulfate Proteoglycans | 2 | 2009 | 47 | 0.080 |
Why?
| | Encephalitis | 1 | 1987 | 20 | 0.080 |
Why?
| | Cryoglobulinemia | 1 | 1987 | 2 | 0.080 |
Why?
| | Anterior Compartment Syndrome | 1 | 1987 | 1 | 0.080 |
Why?
| | Antigens | 1 | 2007 | 29 | 0.080 |
Why?
| | Axons | 1 | 2007 | 42 | 0.080 |
Why?
| | Femoral Nerve | 1 | 1987 | 8 | 0.080 |
Why?
| | Elbow Joint | 1 | 1989 | 132 | 0.080 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2007 | 36 | 0.080 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 111 | 0.080 |
Why?
| | Synovitis | 1 | 1987 | 22 | 0.080 |
Why?
| | Compartment Syndromes | 1 | 1987 | 10 | 0.080 |
Why?
| | Heparin | 1 | 1987 | 37 | 0.080 |
Why?
| | Thigh | 1 | 1987 | 36 | 0.080 |
Why?
| | Pelvis | 1 | 1987 | 26 | 0.080 |
Why?
| | Matrix Metalloproteinase 13 | 3 | 2014 | 36 | 0.080 |
Why?
| | Muscular Diseases | 1 | 1987 | 23 | 0.080 |
Why?
| | Osteolysis | 1 | 1988 | 141 | 0.080 |
Why?
| | Nerve Fibers | 1 | 2006 | 17 | 0.080 |
Why?
| | Sciatic Nerve | 1 | 1987 | 32 | 0.080 |
Why?
| | Injections, Intralesional | 1 | 2006 | 33 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2006 | 47 | 0.080 |
Why?
| | Fibrocartilage | 1 | 2006 | 9 | 0.080 |
Why?
| | Sports | 1 | 1987 | 36 | 0.080 |
Why?
| | Bone Neoplasms | 1 | 1988 | 121 | 0.080 |
Why?
| | Fluorescent Dyes | 1 | 2006 | 71 | 0.080 |
Why?
| | Plasma | 1 | 2006 | 36 | 0.080 |
Why?
| | Pilot Projects | 2 | 2005 | 455 | 0.080 |
Why?
| | Surgical Wound Infection | 2 | 2006 | 106 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 63 | 0.080 |
Why?
| | Joints | 3 | 2008 | 101 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 389 | 0.080 |
Why?
| | Surgical Wound Dehiscence | 1 | 2006 | 12 | 0.080 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2017 | 84 | 0.070 |
Why?
| | Blood Sedimentation | 1 | 2006 | 65 | 0.070 |
Why?
| | Creatine Kinase | 1 | 2006 | 36 | 0.070 |
Why?
| | Hip Dislocation | 1 | 1987 | 59 | 0.070 |
Why?
| | Therapeutic Irrigation | 1 | 2006 | 69 | 0.070 |
Why?
| | Cricetinae | 1 | 2005 | 52 | 0.070 |
Why?
| | Ultrasonic Therapy | 1 | 2005 | 22 | 0.070 |
Why?
| | Tendons | 1 | 2008 | 212 | 0.070 |
Why?
| | Shoulder | 1 | 1987 | 156 | 0.070 |
Why?
| | Research | 1 | 2006 | 64 | 0.070 |
Why?
| | Fluorescent Antibody Technique, Direct | 1 | 2005 | 5 | 0.070 |
Why?
| | Abdominal Muscles | 1 | 1985 | 8 | 0.070 |
Why?
| | In Situ Nick-End Labeling | 1 | 2005 | 17 | 0.070 |
Why?
| | Ovariectomy | 1 | 2005 | 29 | 0.070 |
Why?
| | Baseball | 1 | 1987 | 104 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2005 | 117 | 0.070 |
Why?
| | Wounds, Stab | 1 | 2005 | 1 | 0.070 |
Why?
| | Phenotype | 2 | 2021 | 379 | 0.070 |
Why?
| | Water | 1 | 2005 | 37 | 0.070 |
Why?
| | Needles | 1 | 2005 | 18 | 0.070 |
Why?
| | Glucuronic Acid | 3 | 2013 | 10 | 0.070 |
Why?
| | Hexuronic Acids | 3 | 2013 | 12 | 0.070 |
Why?
| | Alginates | 3 | 2013 | 12 | 0.070 |
Why?
| | Wound Healing | 2 | 2005 | 175 | 0.070 |
Why?
| | Motion | 2 | 2001 | 28 | 0.070 |
Why?
| | Athletic Injuries | 1 | 1987 | 182 | 0.070 |
Why?
| | Bony Callus | 1 | 2004 | 7 | 0.070 |
Why?
| | Spinal Injuries | 2 | 2008 | 29 | 0.060 |
Why?
| | Sampling Studies | 1 | 2003 | 32 | 0.060 |
Why?
| | Titanium | 1 | 2005 | 204 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2016 | 687 | 0.060 |
Why?
| | Biolistics | 1 | 2003 | 1 | 0.060 |
Why?
| | Probability | 1 | 2003 | 104 | 0.060 |
Why?
| | Microscopy, Polarization | 1 | 2003 | 2 | 0.060 |
Why?
| | Cell Lineage | 1 | 2003 | 34 | 0.060 |
Why?
| | Alternative Splicing | 2 | 2015 | 32 | 0.060 |
Why?
| | Protein Isoforms | 2 | 2015 | 60 | 0.060 |
Why?
| | Versicans | 1 | 2002 | 25 | 0.060 |
Why?
| | Marfan Syndrome | 1 | 2002 | 3 | 0.060 |
Why?
| | Pressure | 1 | 2002 | 71 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 385 | 0.060 |
Why?
| | Workers' Compensation | 1 | 2002 | 50 | 0.060 |
Why?
| | Lectins, C-Type | 1 | 2002 | 145 | 0.060 |
Why?
| | Linear Models | 2 | 2020 | 276 | 0.060 |
Why?
| | Sex Factors | 3 | 2011 | 542 | 0.060 |
Why?
| | Drug Synergism | 2 | 2013 | 67 | 0.060 |
Why?
| | Receptor, trkA | 2 | 2015 | 9 | 0.060 |
Why?
| | Delphi Technique | 1 | 2022 | 26 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2016 | 21 | 0.060 |
Why?
| | Coculture Techniques | 2 | 2015 | 39 | 0.050 |
Why?
| | Infant | 2 | 2014 | 642 | 0.050 |
Why?
| | Consensus | 1 | 2022 | 106 | 0.050 |
Why?
| | Pliability | 1 | 2001 | 2 | 0.050 |
Why?
| | Radionuclide Imaging | 1 | 2001 | 58 | 0.050 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 71 | 0.050 |
Why?
| | Paraspinal Muscles | 1 | 2020 | 2 | 0.050 |
Why?
| | Neck Muscles | 1 | 2020 | 14 | 0.050 |
Why?
| | Electromagnetic Fields | 1 | 2000 | 12 | 0.050 |
Why?
| | Knee Joint | 1 | 1987 | 775 | 0.050 |
Why?
| | Fetal Blood | 2 | 2013 | 18 | 0.050 |
Why?
| | Perception | 1 | 2021 | 92 | 0.050 |
Why?
| | Matrix Metalloproteinases | 2 | 2012 | 31 | 0.050 |
Why?
| | Electric Stimulation Therapy | 1 | 2000 | 43 | 0.050 |
Why?
| | Cryoultramicrotomy | 1 | 1999 | 2 | 0.050 |
Why?
| | Ligaments | 1 | 2000 | 13 | 0.050 |
Why?
| | Global Health | 1 | 2020 | 60 | 0.050 |
Why?
| | Intermittent Claudication | 1 | 2019 | 7 | 0.050 |
Why?
| | Pelvic Bones | 1 | 2019 | 20 | 0.050 |
Why?
| | NF-kappa B | 2 | 2011 | 112 | 0.050 |
Why?
| | Dissection | 1 | 1999 | 29 | 0.050 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2019 | 2 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2019 | 7 | 0.050 |
Why?
| | Ligaments, Articular | 1 | 2000 | 96 | 0.050 |
Why?
| | Pregnancy | 1 | 2021 | 457 | 0.050 |
Why?
| | Myelography | 2 | 2001 | 10 | 0.050 |
Why?
| | Operative Time | 1 | 2019 | 97 | 0.050 |
Why?
| | Inflammation Mediators | 2 | 2012 | 94 | 0.050 |
Why?
| | Laparoscopy | 1 | 2000 | 190 | 0.050 |
Why?
| | Body Mass Index | 1 | 2021 | 458 | 0.040 |
Why?
| | Decision Making | 1 | 2000 | 232 | 0.040 |
Why?
| | Rats, Nude | 1 | 2018 | 4 | 0.040 |
Why?
| | Arthrodesis | 2 | 2001 | 36 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 14 | 0.040 |
Why?
| | Analgesics | 1 | 2019 | 103 | 0.040 |
Why?
| | Ontario | 1 | 2018 | 18 | 0.040 |
Why?
| | Length of Stay | 2 | 2017 | 377 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2018 | 37 | 0.040 |
Why?
| | Cerebral Ventricles | 1 | 2018 | 26 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 84 | 0.040 |
Why?
| | Cell Count | 2 | 2013 | 115 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2017 | 21 | 0.040 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 109 | 0.040 |
Why?
| | Stem Cells | 1 | 2018 | 52 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2008 | 140 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 986 | 0.040 |
Why?
| | Survival Analysis | 1 | 2018 | 379 | 0.040 |
Why?
| | Patient Care Team | 1 | 1999 | 153 | 0.040 |
Why?
| | Hospital Costs | 1 | 2017 | 73 | 0.040 |
Why?
| | Databases, Bibliographic | 1 | 2016 | 13 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 1997 | 40 | 0.040 |
Why?
| | Survival Rate | 1 | 2018 | 465 | 0.040 |
Why?
| | Swine, Miniature | 2 | 2006 | 9 | 0.040 |
Why?
| | Hand | 1 | 1996 | 49 | 0.040 |
Why?
| | Spinal Cord Injuries | 1 | 1997 | 43 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2018 | 481 | 0.040 |
Why?
| | Swine | 2 | 2006 | 117 | 0.040 |
Why?
| | Drug Utilization | 1 | 2016 | 27 | 0.040 |
Why?
| | Ceramics | 1 | 1995 | 22 | 0.040 |
Why?
| | Posture | 1 | 2016 | 92 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2016 | 49 | 0.040 |
Why?
| | Databases, Factual | 1 | 2017 | 391 | 0.040 |
Why?
| | Freeze Drying | 1 | 1995 | 1 | 0.040 |
Why?
| | Cryopreservation | 1 | 1995 | 25 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 70 | 0.040 |
Why?
| | Esophagus | 1 | 1995 | 60 | 0.030 |
Why?
| | Sternum | 1 | 1994 | 5 | 0.030 |
Why?
| | Astrocytes | 1 | 2016 | 135 | 0.030 |
Why?
| | Heterocyclic Compounds | 1 | 1994 | 11 | 0.030 |
Why?
| | Chronic Pain | 1 | 2016 | 102 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 11 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 1997 | 180 | 0.030 |
Why?
| | Synovial Membrane | 1 | 2015 | 79 | 0.030 |
Why?
| | Proteolysis | 1 | 2014 | 20 | 0.030 |
Why?
| | Transfection | 1 | 2014 | 154 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2014 | 50 | 0.030 |
Why?
| | Gout | 1 | 1993 | 8 | 0.030 |
Why?
| | Tensile Strength | 1 | 2013 | 31 | 0.030 |
Why?
| | Ribs | 1 | 1993 | 19 | 0.030 |
Why?
| | Smad6 Protein | 1 | 2013 | 4 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 12 | 0.030 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2013 | 1 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 3 | 0.030 |
Why?
| | Diagnostic Errors | 2 | 2009 | 48 | 0.030 |
Why?
| | Prevalence | 1 | 2015 | 544 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 25 | 0.030 |
Why?
| | Chondrogenesis | 1 | 2013 | 30 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2016 | 211 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 112 | 0.030 |
Why?
| | Intraoperative Period | 2 | 2003 | 39 | 0.030 |
Why?
| | Elastic Modulus | 1 | 2012 | 15 | 0.030 |
Why?
| | Algorithms | 1 | 2015 | 412 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 49 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 7 | 0.030 |
Why?
| | Anabolic Agents | 1 | 2012 | 6 | 0.030 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 36 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 70 | 0.030 |
Why?
| | Radiopharmaceuticals | 1 | 2012 | 63 | 0.030 |
Why?
| | Regression Analysis | 3 | 2000 | 319 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2012 | 46 | 0.030 |
Why?
| | Epiphyses, Slipped | 1 | 1991 | 1 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 75 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 50 | 0.030 |
Why?
| | Radiography, Interventional | 1 | 1991 | 29 | 0.030 |
Why?
| | Kidney Failure, Chronic | 1 | 1993 | 176 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 115 | 0.030 |
Why?
| | Smad Proteins | 1 | 2010 | 7 | 0.030 |
Why?
| | Femur Head | 1 | 1991 | 58 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 1990 | 8 | 0.030 |
Why?
| | Permeability | 1 | 2010 | 143 | 0.030 |
Why?
| | Fractures, Open | 1 | 1990 | 4 | 0.030 |
Why?
| | Biometry | 1 | 2009 | 6 | 0.020 |
Why?
| | Body Weights and Measures | 1 | 2009 | 7 | 0.020 |
Why?
| | Surgical Flaps | 2 | 2006 | 54 | 0.020 |
Why?
| | Collagen Type X | 1 | 2009 | 3 | 0.020 |
Why?
| | Supination | 1 | 1989 | 19 | 0.020 |
Why?
| | Vitis | 1 | 2008 | 1 | 0.020 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2008 | 10 | 0.020 |
Why?
| | Keratan Sulfate | 1 | 2009 | 27 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 12 | 0.020 |
Why?
| | Microcirculation | 1 | 1988 | 40 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 40 | 0.020 |
Why?
| | Gene Transfer Techniques | 1 | 2008 | 36 | 0.020 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2008 | 7 | 0.020 |
Why?
| | Observation | 1 | 2008 | 16 | 0.020 |
Why?
| | Vascular Diseases | 1 | 1988 | 59 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 32 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2008 | 57 | 0.020 |
Why?
| | Body Water | 1 | 2007 | 7 | 0.020 |
Why?
| | Caspase Inhibitors | 1 | 2007 | 6 | 0.020 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2007 | 4 | 0.020 |
Why?
| | Caspase 9 | 1 | 2007 | 10 | 0.020 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2007 | 6 | 0.020 |
Why?
| | Cathepsins | 1 | 2007 | 11 | 0.020 |
Why?
| | Caspase 8 | 1 | 2007 | 13 | 0.020 |
Why?
| | Caspase 3 | 1 | 2007 | 29 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 124 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2010 | 754 | 0.020 |
Why?
| | Oxidants | 1 | 2007 | 29 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2012 | 1452 | 0.020 |
Why?
| | Accidental Falls | 1 | 1989 | 118 | 0.020 |
Why?
| | Activating Transcription Factor 3 | 1 | 2007 | 1 | 0.020 |
Why?
| | GAP-43 Protein | 1 | 2007 | 2 | 0.020 |
Why?
| | Scapula | 1 | 1988 | 81 | 0.020 |
Why?
| | Receptor, Nerve Growth Factor | 1 | 2007 | 6 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2007 | 217 | 0.020 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2006 | 6 | 0.020 |
Why?
| | Cell Communication | 1 | 2007 | 36 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2007 | 59 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2007 | 108 | 0.020 |
Why?
| | Punctures | 1 | 2006 | 15 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 1987 | 22 | 0.020 |
Why?
| | Platelet Count | 1 | 2006 | 25 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2006 | 8 | 0.020 |
Why?
| | Child, Preschool | 1 | 1989 | 786 | 0.020 |
Why?
| | Needs Assessment | 1 | 2006 | 50 | 0.020 |
Why?
| | Education | 1 | 2006 | 42 | 0.020 |
Why?
| | Coccyx | 1 | 2005 | 2 | 0.020 |
Why?
| | Fractures, Compression | 1 | 2005 | 7 | 0.020 |
Why?
| | Radiosurgery | 1 | 2006 | 43 | 0.020 |
Why?
| | Laparotomy | 1 | 1985 | 25 | 0.020 |
Why?
| | Tail | 1 | 2005 | 4 | 0.020 |
Why?
| | Metacarpophalangeal Joint | 1 | 2005 | 5 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2005 | 38 | 0.020 |
Why?
| | Glycosaminoglycans | 1 | 2005 | 69 | 0.020 |
Why?
| | ROC Curve | 1 | 2002 | 153 | 0.010 |
Why?
| | Sciatica | 1 | 2001 | 3 | 0.010 |
Why?
| | Administration, Topical | 1 | 2001 | 24 | 0.010 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 2001 | 4 | 0.010 |
Why?
| | Edema | 1 | 2001 | 40 | 0.010 |
Why?
| | Nonlinear Dynamics | 1 | 2001 | 19 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2002 | 390 | 0.010 |
Why?
| | Logistic Models | 1 | 2002 | 479 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2000 | 68 | 0.010 |
Why?
| | Lymphocytes | 1 | 2000 | 113 | 0.010 |
Why?
| | Macrophages | 1 | 2000 | 129 | 0.010 |
Why?
| | Gadolinium DTPA | 1 | 1998 | 5 | 0.010 |
Why?
| | Molecular Weight | 1 | 1998 | 58 | 0.010 |
Why?
| | Emergency Medical Technicians | 1 | 1997 | 2 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1997 | 10 | 0.010 |
Why?
| | Resuscitation | 1 | 1997 | 15 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1997 | 60 | 0.010 |
Why?
| | Medical History Taking | 1 | 1997 | 26 | 0.010 |
Why?
| | Physical Examination | 1 | 1997 | 116 | 0.010 |
Why?
| | Papio | 1 | 1995 | 12 | 0.010 |
Why?
| | Equipment Failure | 1 | 1995 | 50 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 1997 | 192 | 0.010 |
Why?
| | Reflex, Abnormal | 1 | 1993 | 1 | 0.010 |
Why?
| | False Negative Reactions | 1 | 1993 | 16 | 0.010 |
Why?
| | Fatal Outcome | 1 | 1993 | 75 | 0.010 |
Why?
| | Ultrasonography | 1 | 1995 | 210 | 0.010 |
Why?
| | Fracture Fixation | 1 | 1993 | 26 | 0.010 |
Why?
| | Wound Infection | 1 | 1990 | 13 | 0.010 |
Why?
| | Nervous System Diseases | 1 | 1990 | 145 | 0.010 |
Why?
| | Sternoclavicular Joint | 1 | 1988 | 5 | 0.010 |
Why?
| | Acromioclavicular Joint | 1 | 1988 | 18 | 0.010 |
Why?
| | Muscles | 1 | 1988 | 77 | 0.010 |
Why?
|
|
An's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|